文献速递生殖医学

博洛尼亚标准与POSEIDON标准作为卵巢低反应患者获得至少一个整倍体胚胎可能性的预测因素:一项对6889个周期的分析

Bologna vs. POSEIDON criteria as predictors of the likelihood of obtaining at least one euploid embryo in poor ovarian response: an analysis of 6,889 cycles.
PubMed 文献 · Fertil Steril · 2023-05-13

这项回顾性队列研究分析了6889个进行胚胎非整倍体遗传学检测的刺激周期,比较博洛尼亚标准和POSEIDON标准诊断的卵巢低反应(POR)患者获得至少一个整倍体囊胚的可能性。POSEIDON I组获得至少一个整倍体胚胎的可能性为97.0%,与非POR周期(91.9%)相似,而后续POSEIDON分组显著降低,博洛尼亚标准组最低(31.9%)。

要点

  • POSEIDON I组获得至少一个整倍体胚胎的可能性为97.0%,与非POR周期(91.9%)相似。
  • POSEIDON II、III、IV组获得至少一个整倍体胚胎的可能性分别为77.9%、70.5%、44.8%,逐组显著降低。
  • 博洛尼亚标准诊断的POR周期获得至少一个整倍体胚胎的可能性最低,为31.9%。

核心结论

  • 尽管较年轻的POSEIDON组(I和III)比较年长的组(II和IV)有更高的整倍体率,但每个递增的POSEIDON组别都带来更高的无整倍体囊胚风险;POSEIDON I组与非POSEIDON组无差异,博洛尼亚标准组预后最差。
  • 卵巢储备对整倍体率影响似乎很小,但通过影响卵母细胞获取量,仍是获得至少一个整倍体胚胎可供移植的关键预后因素。
  • 据作者所知,这是首个根据POR程度提供该结局比值比的研究。

研究设计与样本

  • 回顾性队列研究,纳入6889个进行卵巢刺激并意图进行胚胎非整倍体遗传学检测的周期。
  • 应用博洛尼亚标准和POSEIDON分类系统将每个刺激周期区分为POR或非POR,POSEIDON诊断的POR周期进一步分为I、II、III、IV组。

主要发现

  • 共纳入6889个周期,其中3653个(53.0%)按POSEIDON标准归类为POR:I组1.5%(100/6889),II组3.2%(222/6889),III组11.9%(817/6889),IV组36.5%(2514/6889)。
  • 按博洛尼亚标准,23.4%(1612/6889)的周期归类为POR。
  • I组获得至少一个整倍体胚胎的可能性为97.0%(95%置信区间91.5%-99.2%),与非POR周期(91.9%,95%置信区间90.9%-2.8%)相似;II组为77.9%(72.0%-82.9%),III组为70.5%(67.3%-73.5%),IV组为44.8%(42.9%-46.7%),随POSEIDON组别递增显著降低;符合博洛尼亚标准者最低(31.9%,29.7%-34.3%)。
  • 周期获卵量与卵巢储备检测结果相关,而整倍体率与年龄相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the likelihood of obtaining at least 1 euploid embryo for transfer in poor ovarian response (POR) diagnosed per Bologna and Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria, and compare it between groups and with patients without POR. DESIGN: Retrospective cohort study. PATIENTS: Women undergoing an ovarian stimulation cycle with intention to pursue preimplantation genetic testing for aneuploidy. INTERVENTIONS: Bologna criteria and the POSEIDON classification system were applied to characterize each stimulation cycle as POR or not. Cycles identified as POR by POSEIDON were subdivided into groups I, II, III, and IV as defined by this classification system. MAIN OUTCOME MEASURES: The proportion of cycles resulting in at least 1 euploid blastocyst. Other outcome measures included cycle yields (metaphase II oocytes, fertilized oocytes, blastocysts, and euploid blastocysts), and euploidy rate per embryo cohort. RESULTS: A total of 6,889 cycles were included, of which 3,653 (53.0%) were classified as POR per POSEIDON criteria: 1.5% (100/6,889) in group I, 3.2% (222/6,889) in II, 11.9% (817/6,889) in III, and 36.5% (2,514/6,889) in IV. Per Bologna criteria, 23.4% (1,612/6,889) of cycles were classified as POR. Group I had similar likelihood of obtaining at least 1 euploid embryo (97.0%; 95% confidence interval, 91.5%-99.2%) as cycles not deemed POR (91.9%; 95% confidence interval, 90.9%-2.8%), whereas this decreased significantly with each subsequent POSEIDON group (II: 77.9%, 72.0%-82.9%; III: 70.5%, 67.3%-73.5%; IV: 44.8%, 42.9%-46.7%) and those meeting Bologna criteria had the lowest rates (31.9%, 29.7%-34.3%). Cycle yields correlated with ovarian reserve testing results, whereas euploidy rates were associated with age. CONCLUSIONS: Although younger POSEIDON groups (I and III) have higher euploidy rates than older groups (II and IV), each incremental POSEIDON group poses a higher risk of having no euploid blastocysts; with POSEIDON I being no different from non-POSEIDON, and Bologna having the worst prognosis. Although ovarian reserve appears to have little impact on euploidy rates, it remains a key prognostic factor for having at least 1 euploid embryo available for transfer through its impact on oocyte yield. To our knowledge, this is the first study to provide the odds ratio of this outcome depending on the degree of POR.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Reig A, Garcia-Velasco JA, Seli E, et al. Bologna vs. POSEIDON criteria as predictors of the likelihood of obtaining at least one euploid embryo in poor ovarian response: an analysis of 6,889 cycles. Fertil Steril. 2023. PMID: 37187313. doi:10.1016/j.fertnstert.2023.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。